Topics

‘Disappointing’ efficacy for ASIT Biotech’s pollen drug

04:26 EST 4 Dec 2019 | PharmaTimes

The drug only managed to reach an efficacy of 7.4% in 'peak season' and 9.8% in the whole season, falling short of the expected 20%.

Original Article: ‘Disappointing’ efficacy for ASIT Biotech’s pollen drug

NEXT ARTICLE

More From BioPortfolio on "‘Disappointing’ efficacy for ASIT Biotech’s pollen drug"

Quick Search

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...